Can AI Make Better Drugs? Not on Wall Street’s Timeline
Published in Artificial Intelligence, Financial, General News.
The technology has arrived in the drug lab. But should investors pay up for it?
A Genentech computational biologist has built a ‘lab in a loop’ with the help of AI.
Artificial intelligence has proven it can speed up what humans already know how to do: write software, summarize earnings calls and automate routine tasks.
Whether it can help discover what humans don’t yet know is the trillion-dollar question. Nothing would validate AI’s promise more than improving the process of creating medicines for diseases like Alzheimer’s and cancer.
https://www.wsj.com/tech/ai/can-ai-make-better-drugs-not-on-wall-streets-timeline-98a50d9d